Levocarnitine Injection

DRUG3 trials

Sponsors

Lee's Pharmaceutical Limited, The First Affiliated Hospital of Zhejiang Chinese Medical University, Shaikh Zayed Hospital, Lahore

Conditions

AnemiaEnd-Stage Renal DiseaseHeart Failure,Kidney FailureRenal Dialysis

Phase 2

The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure

CompletedNCT01580553

Lee's Pharmaceutical LimitedHeart Failure,

Start: 2011-01-31End: 2012-03-31Updated: 2012-04-27

Phase 4

Effects of L-carnitine Therapy on the Heart of Maintenance Hemodialysis Patients

CompletedNCT05673239

The First Affiliated Hospital of Zhejiang Chinese Medical UniversityRenal Dialysis

Start: 2023-01-15End: 2024-06-30Updated: 2024-08-06

Levocarnitine for Reducing ESA Requirements in Hemodialysis Patients With Renal Anemia

Not yet recruitingNCT07160452

Shaikh Zayed Hospital, LahoreAnemia, End-Stage Renal Disease, Kidney Failure +1

Start: 2025-09-15End: 2026-03-15Target: 94Updated: 2025-09-12